| Website | chlmedical.com |
| Phone | (203)324-7700 |
| Employees | |
| Founded | 1990 |
| Description | Venture capital Firm |
CHL Medical Partners is a premier venture capital firm dedicated to partnering with entrepreneurs and inventors to create and finance innovative biotechnology, molecular diagnostic, healthcare service and medical device companies. Our team is well-known among industry observers and healthcare investment professionals for identifying and validating visionary scientific ideas and healthcare service models and then creating businesses with extraordinary market potential around these breakthrough concepts. Collectively, we have invested in and grown more than 80 start-ups, establishing a notable track record of building prominent companies with products and services that significantly improve patient care. We are currently investing from our sixth fund, the $120 million CHL Medical Partners III, L.P.
| Company | Date | Round | Size | Participants |
| Mevion Medical Systems | 1/12 | Unattributed | $45M | 3 |
| Valeritas | 9/11 | Series C | $150M | 8 |
| DICOM Grid | 11/10 | Series A | $7.5M | 2 |
| Vascular Pathways | 11/10 | Series B | $14M | 4 |
| OpGen | 9/10 | Series B | $17M | 5 |
| Vertos Medical | 1/10 | Series D | $15.5M | 5 |
| PrimeraDx | 10/09 | Series C | $20M | 6 |
| VaxInnate | 6/09 | Series D | $30M | 7 |
| Still River Systems | 1/09 | Unattributed | $33M | 1 |
| POINT Biomedical | 1/08 | Series E | $25M | 4 |
| OpGen | 9/07 | Series A | $23.6M | 4 |
| VaxInnate | 10/06 | Series C | $40M | 6 |